Log In
Print this Print this

dofetilide (Tikosyn)

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionSelective potassium channel blocker
Molecular Target Potassium channel
Mechanism of ActionK channel blocker
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationFibrillation
Indication DetailsDelay atrial fibrillation (AF)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today